{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:35:07Z","timestamp":1780464907283,"version":"3.54.1"},"reference-count":30,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Backgrounds\/Objectives: Malignant pleural effusion (MPE) is a frequent complication of advanced cancer, and talc pleurodesis via video-assisted thoracoscopic surgery (VATS) represents a standard palliative treatment with high efficacy. However, evidence regarding synchronous bilateral pleurodesis in patients with bilateral MPE is limited. This study evaluates the feasibility, safety, and outcomes of a single-stage bilateral VATS talc pleurodesis approach. Materials and Methods: We retrospectively analyzed patients undergoing synchronous bilateral VATS talc poudrage between 2000 and 2025 at a single tertiary cancer center. Inclusion criteria included adult patients with bilateral MPE, expandable lungs, and suitability for surgery. Preoperative assessment involved imaging and multidisciplinary evaluation. Perioperative data, complications, mortality, and recurrence rates at 30 days and 3 months were collected. Survival and pleural effusion-free survival were estimated using the Kaplan\u2013Meier method. Results: Thirty patients were included (median age 63.2 years). The most common primary tumors were breast (43%), lung (30%), and ovarian cancer (17%). Mean operative time was 78.6 min, with no intraoperative complications. Mean hospital stay was 6 days. Postoperative morbidity included atrial fibrillation (13%) and respiratory failure (6.6%), both managed conservatively. Thirty-day mortality was 3%. Pleural effusion recurrence occurred in 6.6% at 3 months and 10% at 7 months. Mean follow-up was 9.7 months. Conclusions: Synchronous bilateral VATS talc pleurodesis is a feasible and safe procedure in selected patients with bilateral MPE with acceptable morbidity. Further prospective studies are needed to confirm these findings and refine patient selection.<\/jats:p>","DOI":"10.3390\/cancers18111676","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T09:17:09Z","timestamp":1779441429000},"page":"1676","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety and Efficacy of Single-Stage Synchronous Bilateral VATS Talc Poudrage for Malignant Pleural Effusion"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5330-5495","authenticated-orcid":false,"given":"Antonio","family":"Mazzella","sequence":"first","affiliation":[{"name":"Division of Thoracic Surgery, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6228-7165","authenticated-orcid":false,"given":"Sara","family":"Degiovanni","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1044-2525","authenticated-orcid":false,"given":"Elena","family":"Mariani","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Cerretani","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1153-3334","authenticated-orcid":false,"given":"Luca","family":"Bertolaccini","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy"},{"name":"Department of Oncology and Haemato-Oncology, University of Milan, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-7811","authenticated-orcid":false,"given":"Monica","family":"Casiraghi","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy"},{"name":"Department of Oncology and Haemato-Oncology, University of Milan, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7482-1544","authenticated-orcid":false,"given":"Giulia","family":"Sedda","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2629-7781","authenticated-orcid":false,"given":"Giorgio","family":"Lo Iacono","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Spaggiari","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy"},{"name":"Department of Oncology and Haemato-Oncology, University of Milan, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1183\/09031936.01.00225601","article-title":"Management of malignant pleural effusions","volume":"18","author":"Antony","year":"2001","journal-title":"Eur. Respir. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","article-title":"Predicting survival in malignant pleural effusion: Development and validation of the LENT prognostic score","volume":"69","author":"Clive","year":"2014","journal-title":"Thorax"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.arbres.2013.11.007","article-title":"Etiology of pleural effusions: Analysis of more than 3.000 consecutive thoracenteses","volume":"50","author":"Porcel","year":"2014","journal-title":"Arch. Bronconeumol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/icvts\/ivv378","article-title":"Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in diagnosis of pleural effusion of malignant origin","volume":"22","author":"Fiorelli","year":"2016","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0025-6196(11)60848-3","article-title":"Recent advances in the diagnosis and management of malignant pleural effusions","volume":"83","author":"Heffner","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"ii32","DOI":"10.1136\/thx.2010.136994","article-title":"BTS Pleural Disease Guideline Group. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010","volume":"65","author":"Roberts","year":"2010","journal-title":"Thorax"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ejcts\/ezy258","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"55","author":"Bibby","year":"2019","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/jama.2012.5535","article-title":"Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: The TIME2 randomized controlled trial","volume":"307","author":"Davies","year":"2012","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1378\/chest.127.3.909","article-title":"Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion","volume":"127","author":"Dresler","year":"2005","journal-title":"Chest"},{"key":"ref_10","first-page":"CD002916","article-title":"WITHDRAWN: Pleurodesis for malignant pleural effusions","volume":"2013","author":"Shaw","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000335419","article-title":"Mechanisms of pleurodesis","volume":"83","year":"2012","journal-title":"Respiration"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.21037\/jovs.2018.05.02","article-title":"Treatment of malignant pleural effusion","volume":"4","author":"Terra","year":"2018","journal-title":"J. Vis. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Lovato, J.B., Aujayeb, A., Duysinx, B., and Astoul, P. (2025). The Evolving Role of Medical Thoracoscopy for the Management of Malignant Pleural Effusion. Curr. Oncol., 32.","DOI":"10.3390\/curroncol32120670"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/cncr.21623","article-title":"Video-assisted management of malignant pleural effusion in breast carcinoma","volume":"106","author":"Gasparri","year":"2006","journal-title":"Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1378\/chest.126.5.1522","article-title":"Talc pleurodesis: Basic fibroblast growth factor mediates pleural fibrosis","volume":"126","author":"Antony","year":"2004","journal-title":"Chest"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Xia, H., Wang, X.J., Zhou, Q., Shi, H.Z., and Tong, Z.H. (2014). Efficacy and safety of talc pleurodesis for malignant pleural effusion: A meta-analysis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087060"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ejcts.2005.12.025","article-title":"The evidence on the effectiveness of management for malignant pleural effusion: A systematic review","volume":"29","author":"Tan","year":"2006","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1164\/rccm.200311-1579OC","article-title":"Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size","volume":"170","author":"Maskell","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1378\/chest.122.3.1018","article-title":"Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis","volume":"122","author":"Ferrer","year":"2002","journal-title":"Chest"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(07)60708-9","article-title":"Safety of pleurodesis with talc poudrage in malignant pleural effusion: A prospective cohort study","volume":"369","author":"Janssen","year":"2007","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1183\/09031936.00189710","article-title":"Short-term safety of thoracoscopic talc pleurodesis for recurrent primary spontaneous pneumothorax: A prospective European multicentre study","volume":"38","author":"Bridevaux","year":"2011","journal-title":"Eur. Respir. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMra1403503","article-title":"Pleural disease","volume":"378","author":"Light","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<1992::AID-CNCR16>3.0.CO;2-M","article-title":"A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions","volume":"86","author":"Putnam","year":"1999","journal-title":"Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Mazzella, A., Caffarena, G., Bardoni, C., Nicolosi, G., Maisonneuve, P., Cerretani, G., Sedda, G., Bertolaccini, L., Lo Iacono, G., and Casiraghi, M. (2025). Recurrent Malignant Pericardial Effusion Management: The Pericardio-Peritoneal Window. J. Clin. Med., 15.","DOI":"10.3390\/jcm15010083"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1378\/chest.13-2481","article-title":"Comparing cost of indwelling pleural catheter vs talc pleurodesis for malignant pleural effusion","volume":"146","author":"Penz","year":"2014","journal-title":"Chest"},{"key":"ref_26","first-page":"414","article-title":"Current practices in the management of malignant pleural effusions: A survey among members of the European Society of Thoracic Surgeons","volume":"24","author":"Scarci","year":"2017","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1053\u20131057; discussion 1057-9","DOI":"10.1016\/j.athoracsur.2012.01.103","article-title":"Thoracoscopic talc versus tunneled pleural catheters for palliation of malignant pleural effusions","volume":"94","author":"Hunt","year":"2012","journal-title":"Ann. Thorac. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Dubus, T., Ozturk, E.B., Cangel, G., and Ceyran, O. (2026). Clinical outcomes of video-assisted thoracoscopic surgery, talc pleurodesis and indwelling catheterisation for malignant pleural effusion: A retrospective comparative study. J. Minimal Access Surg.","DOI":"10.4103\/jmas.jmas_487_25"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1183\/09031936.00164706","article-title":"Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis","volume":"30","author":"Tremblay","year":"2007","journal-title":"Eur. Respir. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/CMAR.S95663","article-title":"Management of malignant pleural effusion: Challenges and solutions","volume":"9","author":"Penz","year":"2017","journal-title":"Cancer Manag. Res."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/11\/1676\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T09:33:58Z","timestamp":1779442438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/11\/1676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["cancers18111676"],"URL":"https:\/\/doi.org\/10.3390\/cancers18111676","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]}}}